HowellA.: The UK experience with Faslodex®. Mini Symposium II: Selective Estrogen Receptor Modulators (SERMs). 21st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 1998.
2.
DeFriendD.J., HowellA., NicholsonR.I.: Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.Cancer Res1994; 54, 408–414.
3.
WakelingA.E.: The future of new pure antiestrogens in clinical breast cancer.Breast Cancer Res Treat1993; 25, 1–9.
4.
BuzdarA.U., JonatW., HowellA.: Significant improved survival with Arimidex (anastrozole) vs megestrol acetate (MA) in postmenopausal advanced breast cancer: updated results of two randomized trials.Proc Am Soc Clin Oncol1997, A545.
5.
BonneterreJ., ThurlimannB.J.K., RobertsonJ.F.R.: Preliminary results of a large comparative multicentre clinical trial comparing the efficacy and tolerability of Arimidex (anastrozole) and Tamoxifen (TAM) in postmenopausal women with advanced breast cancer (ABC).Proc ECCO10: A1257, Sept 12-16, 1999, Vienna, Austria.
6.
PritchardK.I.: New approaches to advanced breast cancer.Proc ECCO 10 - Sept 12-16, 1999, Vienna, Austria.
7.
Milla SantosA., MillaL., RalloL.: Anastrozole vs tamoxifen in hormone-dependent advanced breast cancer. A phase II randomized trial.Breast Cancer Res Treat2000; 64 (1): A173.
8.
BursteinH.J., WinerE.: Primary care for survivors of breast cancer.NEJM2000; 343: 1086.
9.
PaganiO.: Prognostic impact of amenorrea after chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international breast cancer study group trial VI.Eur J Cancer1998; 34: 632–640.
10.
BoccardoF., RubagottiA., AmorosoD.: Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial.J Clin Onc2000; 18: 2718–2727.
11.
JakeszR.: Eur J Surg Oncol2000; 26: A110.
12.
HoughtonJ.: ASCO2000; 19: A359.
13.
BaumM.: Breast Cancer Res Treat1999; 57: A24.
14.
DavidsonN.E.: Breast1999; 8: 232–233, A069.
15.
KuterI.: Breast cancer highlights.Oncologist1999; 4: 299–308.
16.
AebiS., GelberS., Castiglione-GertschM.: Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?Lancet2000; 355: 1869–1874.
